Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Allergy & Immunology
•
Pulmonology
•
General Pulmonary
•
Obstructive Lung Disease
•
Asthma
Is methacholine challenge on its way out?
Answer from: at Academic Institution
I have not needed to order the challenge test for a long time now. I see the need for this test is declining.
Comments
at Mission Health
Why is that? Are there data to show it's not usefu...
at Saint Josephs Health Woodland Park
There is a role for methacholine challenge. I orde...
at Mehanni Maged Office
Its benefit is for medicolegal reason only. It's v...
at Critical Doctor On Call
Outside of a university setting, or for medicolega...
at Saint Lawrence Pulmonology
Methacholine challenge test is performed in our in...
at Atrium Medical Center
It is a very sensitive test but not specific and a...
at Wellspan Pulmonary And Sleep Medicine
Asthma is a heterogeneous disease. It is mostly cl...
11627
11637
11646
11650
12345
12360
15055
Sign In
or
Register
to read more
21624
Related Questions
Do you utilize cytokine panels to guide treatment of patients with EGPA?
Are there benefits to adding IL5/IL5 receptor blockade in patients with vasculitic manifestations of EGPA?
Which biologics for asthma have data regarding mucus plugging?
Do you plan to use benralizumab to treat acute exacerbations of asthma or COPD associated with eosinophilia?
Would you stop Dupixent in an asthma patient who has good asthma control and notes improvement in loss of smell, but shows notable eosinophil elevation after 4-5 doses of the medication?
Are there certain clinical features that help you choose between benralizumab and mepolizumab for EGPA in clinical practice?
Should thunderstorm asthma be incorporated into asthma action plans?
Do you recommend that your patients with COPD avoid gabapentin or pregabalin entirely, given the increased rate of exacerbations noted in patients on these medications?
How do you approach patients who identify so strongly with being sick or with a particular diagnostic label that it makes up a significant portion of their identity?
How do you mitigate the risk of inadverdent under or over diagnosis of COPD in certain populations with transition to race-neutral spirometry reference equations?
Why is that? Are there data to show it's not usefu...
There is a role for methacholine challenge. I orde...
Its benefit is for medicolegal reason only. It's v...
Outside of a university setting, or for medicolega...
Methacholine challenge test is performed in our in...
It is a very sensitive test but not specific and a...
Asthma is a heterogeneous disease. It is mostly cl...